Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (Shanchol) in Subjects Aged 1 Year and Older in the Philippines
Phase of Trial: Phase IV
Latest Information Update: 10 Sep 2015
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 10 Sep 2015 Status changed from active, no longer recruiting to completed.
- 17 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov record.
- 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.